Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filipa Macedo

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Oncology|February 13, 2019
Current opinion about antimicrobial therapy in palliative care: an updateFilipa Macedo, Nuno Bonito
International Journal of Clinical Pharmacy|October 12, 2012
Off-label drug prescribing in a Portuguese paediatric emergency unitMarina Ribeiro, Arminda Jorge, Ana Filipa Macedo
European Journal of Clinical Pharmacology|April 3, 2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlierCarlos Alves, Francisco Batel Marques, Ana Filipa Macedo
European Journal of Clinical Pharmacology|July 30, 2013
Sources of information used by regulatory agencies on the generation of drug safety alertsCarlos Alves, Ana Filipa Macedo, Francisco Batel Marques
Journal of Cardiovascular Pharmacology and Therapeutics|December 3, 2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysisCarlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
International Journal of Clinical Pharmacy|April 25, 2012
Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using START criteriaElisabete Pinto Borges, Manuel Morgado, Ana Filipa Macedo
Pharmacoepidemiology and Drug Safety|October 26, 2011
Data sources on drug safety evaluation: a review of recent published meta-analysesCarlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
Acta Medica Portuguesa|June 21, 2012
[Chronic medication in the perioperative period: usage profile and risk management]Liliana Castanheira, Ana Palmeiro, Paula Fresco, et al.
Journal of Nursing Management|April 22, 2011
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactionsAna Filipa Macedo, Carlos Alves, Nuno Craveiro, et al.
Journal of Gastric Cancer|March 25, 2017
Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?Filipa Macedo, Kátia Ladeira, Adhemar Longatto-Filho, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Oncology|February 13, 2019
Current opinion about antimicrobial therapy in palliative care: an updateFilipa Macedo, Nuno Bonito
International Journal of Clinical Pharmacy|October 12, 2012
Off-label drug prescribing in a Portuguese paediatric emergency unitMarina Ribeiro, Arminda Jorge, Ana Filipa Macedo
European Journal of Clinical Pharmacology|April 3, 2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlierCarlos Alves, Francisco Batel Marques, Ana Filipa Macedo
European Journal of Clinical Pharmacology|July 30, 2013
Sources of information used by regulatory agencies on the generation of drug safety alertsCarlos Alves, Ana Filipa Macedo, Francisco Batel Marques
Journal of Cardiovascular Pharmacology and Therapeutics|December 3, 2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysisCarlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
International Journal of Clinical Pharmacy|April 25, 2012
Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using START criteriaElisabete Pinto Borges, Manuel Morgado, Ana Filipa Macedo
Pharmacoepidemiology and Drug Safety|October 26, 2011
Data sources on drug safety evaluation: a review of recent published meta-analysesCarlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
Acta Medica Portuguesa|June 21, 2012
[Chronic medication in the perioperative period: usage profile and risk management]Liliana Castanheira, Ana Palmeiro, Paula Fresco, et al.
Journal of Nursing Management|April 22, 2011
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactionsAna Filipa Macedo, Carlos Alves, Nuno Craveiro, et al.
Journal of Gastric Cancer|March 25, 2017
Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?Filipa Macedo, Kátia Ladeira, Adhemar Longatto-Filho, et al.
Pageof 3